Metabolic CO2 removal by dialysis: THAM vs NaOH infusion.
New methods of respiratory support are needed to reduce the high mortality rate of acute respiratory failure. To simplify the procedures of extracorporeal CO2 elimination under apneic oxygenation, one approach is to replace the membrane lung by a hemodialyzer and to administer an alkali, since hemodialysis requires a lower blood flow rate than blood-gas exchange. This study compared the effectiveness of trishydroxymethyl aminomethane (THAM) and NaOH in this procedure. Twelve male Anglo-Poitevin dogs (25 to 33 kg) were anesthetized, curarized and mechanically hypoventilated (VE = 41% of the control value). After not less than 15 min, a venovenous shunt was used for dialysis with blood flow of 7-10 ml. min.-1kg-1 for at least 8 hours. The dialysate contained no acetate, bicarbonate or lactate, but was alkalinized to a pH of 8-9 by the addition of NaOH. A solution of THAM (0.5 N) was infused into the right heart at the rate of 0.30 ml.min.-1kg-1 in six animals, and NaOH (0.15 N) was infused in the other six at the rate of 0.80 ml.min-1kg-1. The injected volumes were compensated for by an equivalent amount of ultrafiltration. Elimination of CO2 (mean TCO2 = 2.3 ml.min.-1kg-1) was the same with both methods and the difference for the electrolytes and acid-base equilibrium was only very small. However, hemolysis was six times greater with NaOH than with THAM. Despite ultrafiltration, a similar marked weight gain was observed from the second hour of the experiment in the NaOH series, but only after 7 hours with THAM. It thus appears that hemodialysis combined with alkalinisation is still too complex a procedure to be safely applied in acute or chronic pulmonary failure.
Gille
J P
JP
INSERM U 14, Plateau de Brabois, Vandoeuvre-les-Nancy, France.
Saunier
C
C
Schrijen
F
F
Hartemann
D
D
Tousseul
B
B
D000138:Acidosis / Q000188:drug therapy; D000818:Animals; D002245:Carbon Dioxide / Q000097:blood*; D015314:Dialysis Solutions; D004285:Dogs; D006454:Hemoglobins; D008297:Male; D006435:Renal Dialysis / Q000295:instrumentation / Q000379:methods*; D012119:Respiration; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000628:therapy*; D012972:Sodium Hydroxide / Q000627:therapeutic use*; D014325:Tromethamine / Q000627:therapeutic use*
D015314:Dialysis Solutions; D006454:Hemoglobins; D014325:Tromethamine; D002245:Carbon Dioxide; D012972:Sodium Hydroxide